Cargando…
Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients()
Three-dimensional quantitative ultrasound spectroscopic imaging of prostate was investigated clinically for the noninvasive detection and extent characterization of disease in cancer patients and compared to whole-mount, whole-gland histopathology of radical prostatectomy specimens. Fifteen patients...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350638/ https://www.ncbi.nlm.nih.gov/pubmed/25749174 http://dx.doi.org/10.1016/j.tranon.2014.11.005 |
_version_ | 1782360213552103424 |
---|---|
author | Sadeghi-Naini, Ali Sofroni, Ervis Papanicolau, Naum Falou, Omar Sugar, Linda Morton, Gerard Yaffe, Martin J. Nam, Robert Sadeghian, Alireza Kolios, Michael C. Chung, Hans T. Czarnota, Gregory J. |
author_facet | Sadeghi-Naini, Ali Sofroni, Ervis Papanicolau, Naum Falou, Omar Sugar, Linda Morton, Gerard Yaffe, Martin J. Nam, Robert Sadeghian, Alireza Kolios, Michael C. Chung, Hans T. Czarnota, Gregory J. |
author_sort | Sadeghi-Naini, Ali |
collection | PubMed |
description | Three-dimensional quantitative ultrasound spectroscopic imaging of prostate was investigated clinically for the noninvasive detection and extent characterization of disease in cancer patients and compared to whole-mount, whole-gland histopathology of radical prostatectomy specimens. Fifteen patients with prostate cancer underwent a volumetric transrectal ultrasound scan before radical prostatectomy. Conventional-frequency (~ 5 MHz) ultrasound images and radiofrequency data were collected from patients. Normalized power spectra were used as the basis of quantitative ultrasound spectroscopy. Specifically, color-coded parametric maps of 0-MHz intercept, midband fit, and spectral slope were computed and used to characterize prostate tissue in ultrasound images. Areas of cancer were identified in whole-mount histopathology specimens, and disease extent was correlated to that estimated from quantitative ultrasound parametric images. Midband fit and 0-MHz intercept parameters were found to be best associated with the presence of disease as located on histopathology whole-mount sections. Obtained results indicated a correlation between disease extent estimated noninvasively based on midband fit parametric images and that identified histopathologically on prostatectomy specimens, with an r(2) value of 0.71 (P < .0001). The 0-MHz intercept parameter demonstrated a lower level of correlation with histopathology. Spectral slope parametric maps offered no discrimination of disease. Multiple regression analysis produced a hybrid disease characterization model (r(2) = 0.764, P < .05), implying that the midband fit biomarker had the greatest correlation with the histopathologic extent of disease. This work demonstrates that quantitative ultrasound spectroscopic imaging can be used for detecting prostate cancer and characterizing disease extent noninvasively, with corresponding gross three-dimensional histopathologic correlation. |
format | Online Article Text |
id | pubmed-4350638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Neoplasia Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43506382015-03-09 Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients() Sadeghi-Naini, Ali Sofroni, Ervis Papanicolau, Naum Falou, Omar Sugar, Linda Morton, Gerard Yaffe, Martin J. Nam, Robert Sadeghian, Alireza Kolios, Michael C. Chung, Hans T. Czarnota, Gregory J. Transl Oncol Article Three-dimensional quantitative ultrasound spectroscopic imaging of prostate was investigated clinically for the noninvasive detection and extent characterization of disease in cancer patients and compared to whole-mount, whole-gland histopathology of radical prostatectomy specimens. Fifteen patients with prostate cancer underwent a volumetric transrectal ultrasound scan before radical prostatectomy. Conventional-frequency (~ 5 MHz) ultrasound images and radiofrequency data were collected from patients. Normalized power spectra were used as the basis of quantitative ultrasound spectroscopy. Specifically, color-coded parametric maps of 0-MHz intercept, midband fit, and spectral slope were computed and used to characterize prostate tissue in ultrasound images. Areas of cancer were identified in whole-mount histopathology specimens, and disease extent was correlated to that estimated from quantitative ultrasound parametric images. Midband fit and 0-MHz intercept parameters were found to be best associated with the presence of disease as located on histopathology whole-mount sections. Obtained results indicated a correlation between disease extent estimated noninvasively based on midband fit parametric images and that identified histopathologically on prostatectomy specimens, with an r(2) value of 0.71 (P < .0001). The 0-MHz intercept parameter demonstrated a lower level of correlation with histopathology. Spectral slope parametric maps offered no discrimination of disease. Multiple regression analysis produced a hybrid disease characterization model (r(2) = 0.764, P < .05), implying that the midband fit biomarker had the greatest correlation with the histopathologic extent of disease. This work demonstrates that quantitative ultrasound spectroscopic imaging can be used for detecting prostate cancer and characterizing disease extent noninvasively, with corresponding gross three-dimensional histopathologic correlation. Neoplasia Press 2015-03-03 /pmc/articles/PMC4350638/ /pubmed/25749174 http://dx.doi.org/10.1016/j.tranon.2014.11.005 Text en © 2014 Neoplasia Press, Inc. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Article Sadeghi-Naini, Ali Sofroni, Ervis Papanicolau, Naum Falou, Omar Sugar, Linda Morton, Gerard Yaffe, Martin J. Nam, Robert Sadeghian, Alireza Kolios, Michael C. Chung, Hans T. Czarnota, Gregory J. Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients() |
title | Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients() |
title_full | Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients() |
title_fullStr | Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients() |
title_full_unstemmed | Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients() |
title_short | Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients() |
title_sort | quantitative ultrasound spectroscopic imaging for characterization of disease extent in prostate cancer patients() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350638/ https://www.ncbi.nlm.nih.gov/pubmed/25749174 http://dx.doi.org/10.1016/j.tranon.2014.11.005 |
work_keys_str_mv | AT sadeghinainiali quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT sofroniervis quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT papanicolaunaum quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT falouomar quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT sugarlinda quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT mortongerard quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT yaffemartinj quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT namrobert quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT sadeghianalireza quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT koliosmichaelc quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT chunghanst quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients AT czarnotagregoryj quantitativeultrasoundspectroscopicimagingforcharacterizationofdiseaseextentinprostatecancerpatients |